Effects of Basic Fibroblast Growth Factor and Transforming Growth Factor-β on Maturation of Human Pediatric Aortic Cell Culture for Tissue Engineering of Cardiovascular Structures

ASAIO Journal

Volumn 50, Issue 1, 2004, Pages 9-14

  Fu, Ping ^a   Sodian, Ralf ^a   Lüders, Cora ^a   Lemke, Thees ^a   Kraemer, Liv ^a   Hübler, Michael ^a   Weng, Yuguo ^a   Hoerstrup, Simon P ^b   Meyer, Rudolf ^a   Hetzer, Roland ^a  

^a DEUTSCHES HERZZENTRUM BERLIN   (Germany)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTICS; BIOSYNTHESIS; CARDIOVASCULAR SYSTEM; CELL CULTURE; COLLAGEN; DNA; HISTOLOGY; IMPLANTS (SURGICAL);

CARDIOVASCULAR STUCTURES; CELL PROLIFERATION; TISSUE ENGINEERING;

BIOMEDICAL ENGINEERING;

ANTIBIOTIC AGENT; BASIC FIBROBLAST GROWTH FACTOR; BUTYRIC ACID DERIVATIVE; COLLAGEN; POLY(4 HYDROXYBUTYRATE); POLYGLYCOLIC ACID; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

AORTA SURGERY; ARTICLE; BIODEGRADABILITY; BLOOD VESSEL; CARDIOVASCULAR SYSTEM; CELL PROLIFERATION; CHILD; COLLAGEN SYNTHESIS; CONTROLLED STUDY; CULTURE MEDIUM; DNA DETERMINATION; EXTRACELLULAR MATRIX; FETAL CALF SERUM; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMPLANTATION; IN VITRO STUDY; MATERIAL COATING; TISSUE ENGINEERING;

AORTA; ASCORBIC ACID; CARDIOVASCULAR SYSTEM; CELL DIFFERENTIATION; CELL DIVISION; CELLS, CULTURED; CHILD; COLLAGEN; DNA; FIBROBLAST GROWTH FACTOR 2; HUMANS; IMMUNOHISTOCHEMISTRY; TISSUE ENGINEERING; TRANSFORMING GROWTH FACTOR BETA;

EID: 0346690290     PISSN: 10582916     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.MAT.0000104815.21056.08     Document Type: Article

References (23)

1. Langer R, Vacanti JP: Tissue engineering. Science 260: 920-926, 1993.
2. Shinoka T, Breuer CK, Tanel RE, et al: Tissue engineering heart valves: Valve leaflet replacement study in a lamb model. Ann Thorac Surg 60: S513-S516, 1995.
3. Hoerstrup SP, Sodian R, Daebritz S, et al: Functional living trileaflet heart valves grown in vitro. Circulation 102: 11144-11149, 2000.
4. Sodian R, Hoerstrup SP, Sperling JS, et al: Early in vivo experience with tissue-engineered trileaflet heart valves. Circulation 102: 11122-11129, 2000.
5. Sodian R, Lemke T, Loebe M, et al: New pulsatile bioreactor for fabrication of tissue-engineered patches. J Biomed Mater Res 58: 401-405, 2001.
6. Niklason LE, Ratcliffe A, Brockbank K, Bruley DF, Kang KA: Bioreactors and bioprocessing: Breakout session summary. Ann N Y Acad Sci 961: 220-222, 2002.
7. Mayer JE Jr, Shin'oka T, Shum-Tim D: Tissue engineering of cardiovascular structures. Curr Opin Cardiol 12: 528-532, 1997.
8. Carrel A: Landmark article, Nov 14, 1908: Results of the transplantation of blood vessels, organs and limbs. JAMA 250: 944-953, 1983.
9. Jonas RA, Schoen FJ, Levy RJ, Castaneda AR: Biological sealants and knitted Dacron: Porosity and histological comparisons of vascular graft materials with and without collagen and fibrin glue pretreatments. Ann Thorac Surg 41: 657-663, 1986.
10. Hoerstrup SP, Zund G, Schnell AM, et al: Optimized growth conditions for tissue engineering of human cardiovascular structures. Int J Artif Organs 23: 817-823, 2000.
11. Jockenhoevel S, Chalabi K, Sachweh JS, et al: Tissue engineering: Complete autologous valve conduit - A new moulding technique. Thorac Cardiovasc Surg 49: 287-290, 2001.
12. Kurata S, Hata R: Epidermal growth factor inhibits transcription of type I collagen genes and production of type I collagen in cultured human skin fibroblasts in the presence and absence of L-ascorbic acid 2-phosphate, a long-acting vitamin C derivative. J Biol Chem 266: 9997-10003, 1991.
13. Zern MA, Schwartz E, Giambrone MA, Blumenfeld OO: Ascorbate-generated endogenous extracellular matrix affects cell protein synthesis in calf aortic smooth muscle cells. Exp Cell Res 160: 307-318, 1985.
14. D'Amore PA, Smith SR: Growth factor effects on cells of the vascular wall: A survey. Growth Factors 8: 61-75, 1993.
15. Kennedy SH, Qin H, Lin L, Tan EM: Basic fibroblast growth factor regulates type I collagen and collagenase gene expression in human smooth muscle cells. Am J Pathol 146: 764-771, 1995.
16. Thyberg J. Differentiated properties and proliferation of arterial smooth muscle cells in culture. Int Rev Cytol 169: 183-265, 1996.
17. Kaiura TL, Itoh H, Kubaska SM 3rd, McCaffrey TA, Liu B, Kent KC: The effect of growth factors, cytokines, and extracellular matrix proteins on fibronectin production in human vascular smooth muscle cells. J Vasc Surg 31: 577-584, 2000.
18. Filip DA, Radu A, Simionescu M: Interstitial cells of the heart valves possess characteristics similar to smooth muscle cells Circ Res 59: 310-320, 1986.
19. Imegwu OJ, Entersz I, Graham AM, Nackman GB: Heterotypic smooth muscle cell/endothelial cell interactions differ between species. J Surg Res 98: 85-88, 2001.
20. Chan P. Cell biology of human vascular smooth muscle. Ann R Coll Surg Engl 76: 298-303, 1994.
21. Fujita H, Shimokado K, Yutani C, Takaichi S, Masuda J, Ogata J: Human neonatal and adult vascular smooth muscle cells in culture. Exp Mol Pathol 58: 25-39, 1993.
22. Cole WG, Chan D, Hickey AJ, Wilcken DE: Collagen composition of normal and myxomatous human mitral heart valves. Biochem J 219: 451-460, 1984.
23. Song YC, Yao LY, Kneebone JM, Lupinetti FM: Effect of cryopreservation and histocompatibility on type I procollagen gene expression in aortic valve grafts. J Thorac Cardiovasc Surg 114: 421-427, 1997.